ENDO INTERNATIONAL PLC PERFORMANCE AWARD AGREEMENT UNDER THE 2015 STOCK INCENTIVE PLANPerformance Award Agreement • May 6th, 2016 • Endo International PLC • Pharmaceutical preparations • Delaware
This Performance Award Agreement (this “Award Agreement”) is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Endo International plc, an Irish public limited company (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meanings ascribed to them in the Company’s 2015 Stock Incentive Plan (the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
ENDO INTERNATIONAL PLC STOCK AWARD AGREEMENT UNDER THE 2015 STOCK INCENTIVE PLANStock Award Agreement • May 6th, 2016 • Endo International PLC • Pharmaceutical preparations • Delaware
This Stock Award Agreement (this “Award Agreement”), is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Endo International plc, an Irish public limited company (the “Company”), and the participant named below (the “Participant”). Capitalized terms not defined herein shall have the meanings ascribed to them in the Company’s 2015 Stock Incentive Plan (the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
ENDO INTERNATIONAL PLC STOCK OPTION AGREEMENT UNDER THE 2015 STOCK INCENTIVE PLANStock Option Agreement • May 6th, 2016 • Endo International PLC • Pharmaceutical preparations • Delaware
This Stock Option Agreement (this “Option Agreement”) is made and entered into as of the date of grant set forth below (the “Date of Grant”) by and between Endo International plc, an Irish public limited company (the “Company”), and the optionee named below (the “Participant”). Capitalized terms not defined herein shall have the meanings ascribed to them in the Company’s 2015 Stock Incentive Plan (the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
Amendment Number 4 to Supply AgreementSupply Agreement • May 6th, 2016 • Endo International PLC • Pharmaceutical preparations
This Fourth Amendment (“Fourth Amendment”) is entered into on the 22nd day of October, 2015 (“Amendment Effective Date”), by and between Endo Ventures Limited, a corporation organized and existing under the laws of Ireland (registered number 442731) having its principal office at
INDEMNIFICATION AGREEMENTIndemnification Agreement • May 6th, 2016 • Endo International PLC • Pharmaceutical preparations
This Indemnification Agreement (this Agreement) is made as of ________________ , 2016 by and between Endo International plc, a public limited company (company number 534814) with its registered office at First Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4, Ireland (the Company), and _________________ (Indemnitee). This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of this Agreement.
FIFTH AMENDMENT TO SUPPLY AGREEMENTSupply Agreement • May 6th, 2016 • Endo International PLC • Pharmaceutical preparations
This Fifth Amendment to the April 27, 2012 Supply Agreement (the “Fifth Amendment”) is made as of April 25, 2016 (the “Fifth Amendment Effective Date”) by and between Endo Ventures Limited, a company organized and existing under the laws of Ireland (registered number 442731) having its principal office at First Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4, Ireland for itself and its Affiliates, each of which shall be bound by this Fifth Amendment as if each had separately executed this Fifth Amendment, (collectively “Endo”), and Noramco, Inc. a Georgia corporation having a principal place of business at 500 Swedes Landing Road, Wilmington, DE 19801, USA (“Noramco”) hereinafter collectively and/or individually (“Parties” and/or a “Party”).
THIRD AMENDMENT TO SUPPLY AGREEMENTSupply Agreement • May 6th, 2016 • Endo International PLC • Pharmaceutical preparations
This Third Amendment to the April 27, 2012 Supply Agreement (the “Third Amendment”) is made as of January 1, 2015 (the “Effective Date”) by and between Endo Pharmaceuticals Inc., a Delaware limited liability company with offices at 1400 Atwater Drive, Malvern, PA 19355 (“ENDO”) and Noramco, Inc. a Georgia corporation having a principal place of business at 500 Swedes Landing Road, Wilmington, DE 19801, USA (“Noramco”) hereinafter collectively and/or individually (Parties and/or Party).
